EP
TMO icon

Eudaimonia Partners’s Thermo Fisher Scientific TMO Stock Holding History

Eudaimonia Partners’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$243K Buy
418
+13
+3% +$7.29K 0.06% 223
2023
Q4 		$215K Sell
405
-23
-5% -$11.1K 0.06% 232
2023
Q3 		$217K Sell
428
-3
-0.7% -$1.6K 0.05% 292
2023
Q2 		$225K Sell
431
-4
-0.9% -$2.16K 0.05% 301
2023
Q1 		$251K Sell
435
-14
-3% -$7.89K 0.06% 285
2022
Q4 		$247K Buy
449
+19
+4% +$10.1K 0.06% 288
2022
Q3 		$218K Sell
430
-64
-13% -$35.8K 0.06% 294
2022
Q2 		$268K Buy
494
+53
+12% +$29.2K 0.05% 315
2022
Q1 		$260K Buy
+441
New +$253K 0.04% 338
2021
Q3 		$290K Sell
507
-275
-35% -$151K 0.05% 315
2021
Q2 		$394K Buy
782
+199
+34% +$93.9K 0.07% 262
2021
Q1 		$266K Buy
583
+433
+289% +$207K 0.06% 289
2020
Q4 		$70K Sell
150
-386
-72% -$181K 0.02% 533
2020
Q3 		$237K Buy
536
+382
+248% +$158K 0.06% 256
2020
Q2 		$56K Sell
154
-107
-41% -$35.9K 0.02% 473
2020
Q1 		$74K Buy
+261
New +$82.3K 0.03% 388

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Eudaimonia Partners's TMO Position: Q1 2024 in Review

Eudaimonia Partners increased its Thermo Fisher Scientific (TMO) stake by 3.2% in Q1 2024, buying an estimated $7.29K and bringing the position to 418 shares worth $243K. The position accounts for 0.06% of the portfolio, ranked #223.

Eudaimonia Partners first reported a position in TMO in Q1 2020 and has held it in 16 quarters since. The position peaked at $394K in Q2 2021. 2,527 funds tracked by Wall St. Rank hold TMO as of Q1 2024.

  • Eudaimonia Partners held 418 shares of Thermo Fisher Scientific worth $243K as of Q1 2024.
  • Eudaimonia Partners bought 13 Thermo Fisher Scientific shares in Q1 2024, an estimated $7.29K.
  • Thermo Fisher Scientific made up 0.06% of Eudaimonia Partners's portfolio in Q1 2024, its #223 holding.
  • Eudaimonia Partners first reported a position in Thermo Fisher Scientific in Q1 2020 and has held it in 16 quarters since.
  • Eudaimonia Partners's Thermo Fisher Scientific position peaked at $394K in Q2 2021.
  • 2,527 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2024.

Based on Eudaimonia Partners's 13F filing for Q1 2024, filed 25 Apr 2024.